Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

OTHER × Cancer Cachexia × kang-lai-te × Clear all

Phase

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Conditions

Cancer Cachexia 2 Neoplasms 1 Mucositis 1 Head and Neck Neoplasms 1

Interventions

kang-lai-te 2 ruxolitinib 1 Pharmacogenomic Testing 1 Omacor 1 Isophane Insulin, Human 1 Eicosapentaenoic Acid 1 Docosahexaenoic Acids 1 Capsules 1 Absorptiometry, Photon 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03631459 2018-08-21

A Multicenter Real World Study of Kanglaite for Cancer Cachexia

Zhejiang Kanglaite Pharmaceutical Co.Ltd

100,000 enrolled

Cancer Cachexia

NCT02553187 2017-02-15

A Prospective, Randomized, Controlled, Multicenter Study of Kanglaite Injection for the Treatment of Cancer Cachexia

Zhejiang Kanglaite Pharmaceutical Co.Ltd

Phase 4 Unknown

Cancer Cachexia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡